Pure Global AI
ANVISA registration 10339840544Valid until Jul 31, 2033

HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG)

ANVISA Registration Number: 10339840544DIASORIN LTDADIASORIN ITALIA S.P.A. UK BRANCHRisk Class IV
Verified
Device names
Technical name
HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG)
View exact technical-name matches →
PT: ANTÍGENO DE SUPERFÍCIE DE VÍRUS DA HEPATITE B (HBSAG)
Commercial name
Família LIAISON® XL murex HBsAg
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
10339840544
Process Number
25351004278202300
CNPJ
01896764000170
Company information
Registration Holder
DIASORIN LTDA
Manufacturer
DIASORIN ITALIA S.P.A. UK BRANCH
Manufacturing Country
United Kingdom
PT: REINO UNIDO
Dates and status
Publication Date
Jul 31, 2023
Validity
31/07/2033
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10339840544 and manufactured by DIASORIN ITALIA S.P.A. UK BRANCH. The registration is held by DIASORIN LTDA with validity until Jul 31, 2033.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.